Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-04-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于全资子公司再次通过高新技术企业认定的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (590 characters) regarding the re-certification of a wholly-owned subsidiary as a high-tech enterprise, including details about the certificate and tax benefits. It does not contain financial statements, management discussion, or detailed financial data. It is not a report but an announcement of a regulatory or corporate event. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the subsidiary's certification status.
2021-04-19 Chinese
关于拟筹划重大资产重组暨关联交易的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a disclosure announcement by 盈康生命科技股份有限公司 regarding a proposed major asset restructuring and related party transaction. It discusses the planned acquisition of 100% equity of 苏州广慈肿瘤医院有限公司 from 青岛盈康医院管理有限公司, which is controlled by the same ultimate controller 海尔集团公司, making it a related party transaction. The document references the regulatory framework for major asset restructurings and related party transactions under Chinese securities regulations and Shenzhen Stock Exchange rules. It states that the transaction is still in the planning stage and that formal agreements have not been signed yet. The document is a notification of a planned significant transaction and related risks, not a full financial report or detailed management discussion. It is also relatively short (2774 characters) and serves as a preliminary announcement to inform investors of the planned major asset restructuring and related party transaction. Therefore, this document fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes including major asset restructurings and related party transactions.
2021-04-12 Chinese
关于四川友谊医院三级甲等医院评审获得通过的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the successful evaluation and accreditation of a subsidiary hospital as a top-tier (三级甲等) hospital by a provincial health committee. It describes the hospital's facilities, services, and future plans, emphasizing the significance of this accreditation for the company's business. The document is short (1335 characters) and does not contain financial statements, detailed financial data, or regulatory filings. It is an announcement of a significant operational milestone rather than a financial report or regulatory filing. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general Regulatory Filing (RNS) because it is a regulatory announcement about the company's operations and compliance with health authority standards, which does not fit other more specific categories.
2021-04-06 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, compliance with regulations, and future intentions to continue the buyback. It does not contain financial statements or comprehensive financial data but focuses on the update of the share buyback activity. The document length is short (1394 characters) and it is clearly an announcement of the progress of a share repurchase program, fitting the description of a Transaction in Own Shares (POS) filing type.
2021-04-01 Chinese
关于全资子公司出售长沙盈康医院有限公司100%股权暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the progress of a transaction involving the sale of 100% equity of a subsidiary. It details the board meeting approval, the signing of the equity transfer agreement, completion of registration, and payment status. There are no financial statements or comprehensive financial data presented. The document is an update on a capital transaction rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and focused on transaction progress, not a report publication or regulatory filing. Confidence is high due to clear transaction details and absence of other report types.
2021-03-25 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from 盈康生命科技股份有限公司 regarding the company's first share repurchase. It details the board meeting approval, the repurchase plan, the number of shares repurchased, prices, and compliance with relevant regulations. The document does not contain financial statements or detailed financial analysis but focuses on the share buyback activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports the company buying back its own shares. The document length is short (1410 characters), but it contains substantive information about the repurchase, not just a notice of a report publication or certification. Therefore, the correct classification is POS with high confidence.
2021-03-09 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.